John Heymach
MD, PhD
Chair of Thoracic-Head and Neck Medical Oncology
👥Biography 个人简介
John Heymach led the ZENITH20 program investigating poziotinib in HER2 and EGFR exon 20 insertion NSCLC, contributing key clinical data on HER2-selective TKI development. His translational lab defines TKI resistance mechanisms and combination strategies in HER2-altered NSCLC. He shapes thoracic precision oncology programs globally.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 John Heymach 的研究动态
Follow John Heymach's research updates
留下邮箱，当我们发布与 John Heymach（MD Anderson Cancer Center）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment